Phase III Study of AK112 for NSCLC Patients
Phase III Study of AK112 for NSCLC Patients
Active, not recruiting · NCT06396065 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase III Study of AK112 for NSCLC Patients | Non-Squamous Non-small Cell Lung Cancer | Active, not recruiting | Phase 3 | 2026-07-28 | NCT06396065 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Akeso | 89 |
| Summit Therapeutics | 31 |
74 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.